Adjunctive Intravenous Magnesium Sulfate for Postoperative Pain and Opioid Reduction in Lower Extremity Orthopedic Surgery: A Double-Blind Randomized Controlled Trial
Journal of Clinical Medicine · 08.03.2026 · 15 (5) · 2055
DOI: 10.3390/jcm15052055 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.03.2026. Verfasst von Alvian Reza Muhammad und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, University of Indonesia-Dr. Cipto Mangunkusumo National General Hospital, Ja…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background/Objectives: Postoperative pain in lower extremity orthopedic surgery remains inadequately controlled. Magnesium sulfate may serve as an effective adjunct to reduce pain and opioid use. To evaluate the efficacy and safety of intravenous magnesium sulfate (30 mg/kg) as an adjuvant to ketorolac.
Methods
Randomized, double-blind, placebo-controlled, parallel-group superiority trial. Sixty adult patients undergoing elective lower limb orthopedic surgery were randomized (1:1) to receive either intravenous magnesium sulfate (30 mg/kg) or placebo over 60 min before surgery. All patients received standard anesthesia and postoperative ketorolac with morphine PCA. The primary outcomes were postoperative pain (VAS) and morphine consumption over 24 h. Secondary outcomes included time to first analgesic request, serum magnesium levels, and adverse events. Allocation was concealed via opaque envelopes, and blinding was maintained for participants, clinicians, assessors, and analysts.
Results
All 60 patients completed the trial. The magnesium group showed significantly lower VAS scores and reduced 24 h morphine use (median 6 mg vs. 8 mg, p < 0.001), with longer time to first analgesic request (540 vs. 300 min, p < 0.001). Four patients (13%) in the magnesium group had transient hypotension; no serious adverse events occurred.
Conclusions
Low-dose intravenous magnesium sulfate safely reduced pain and opioid needs in orthopedic surgery and may be considered in multimodal analgesia strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Therapy, Faculty of Medicine, University of Indonesia-Dr. Cipto Mangunkusumo National General Hospital, Jakarta 10430, Indonesia.
- Intensive Care Department, University of Indonesia Hospital, Depok 16424, Indonesia.
ORCID-Profile: Elvan Wiyarta
Zitieren
APA
Muhammad, A. R., Sukmono, R. B., Tantri, A. R., & Wiyarta, E. (2026). Adjunctive Intravenous Magnesium Sulfate for Postoperative Pain and Opioid Reduction in Lower Extremity Orthopedic Surgery: A Double-Blind Randomized Controlled Trial. Journal of Clinical Medicine, 15(5), 2055. https://doi.org/10.3390/jcm15052055
Vancouver
Muhammad AR, Sukmono RB, Tantri AR, Wiyarta E. Adjunctive Intravenous Magnesium Sulfate for Postoperative Pain and Opioid Reduction in Lower Extremity Orthopedic Surgery: A Double-Blind Randomized Controlled Trial. Journal of Clinical Medicine. 2026;15(5):2055. doi:10.3390/jcm15052055
BibTeX
@article{Muhammad2026,
author = {Muhammad, Alvian Reza and Sukmono, Raden Besthadi and Tantri, Aida Rosita and Wiyarta, Elvan},
title = {Adjunctive Intravenous Magnesium Sulfate for Postoperative Pain and Opioid Reduction in Lower Extremity Orthopedic Surgery: A Double-Blind Randomized Controlled Trial},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {5},
pages = {2055},
doi = {10.3390/jcm15052055}
}
EUVIMED